---
schema_version: "secwatch.filing_event.v1"
accession: "0001520138-24-000310"
form_type: "8-K"
ticker: "BIVI"
cik: "0001580149"
company_name: "BIOVIE INC."
filed_at: "2024-09-24T23:59:59+00:00"
generated_at: "2026-05-31T02:03:45.595540+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioVie prices $3M public offering of 1.96M units at $1.53/share with warrants

## Summary
- Gross proceeds ~$3M from 1,960,800 units at $1.53 each; each unit includes share or pre-funded warrant plus 5-year warrant exercisable at $1.53.
- Offering expected to close September 25, 2024; ThinkEquity acting as sole placement agent.
- Net proceeds to be used for working capital and general corporate purposes.
- BioVie is a clinical-stage company focused on liver disease and neurodegenerative disorders.

## SEC filing metadata
- accession: 0001520138-24-000310
- form_type: 8-K
- ticker: BIVI
- cik: 0001580149
- company_name: BIOVIE INC.
- filed_at: 2024-09-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1580149/000152013824000310/0001520138-24-000310-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1580149/000152013824000310/bivi-20240923_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001520138-24-000310
- JSON: https://secwatch.observer/filing/0001520138-24-000310.json
- Plain text: https://secwatch.observer/filing/0001520138-24-000310.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.